Impact in Action: A Research Update Webinar

On the 28th July 2026, we were joined by Dr Luke Gaughan from Newcastle University and PCR Patient Advocate Brian Milne for an update on Luke's research project, the importance of continued investment in prostate cancer research, and what your support has helped achieve so far.

For people with advanced prostate cancer, hormone therapy can slow the disease and extend life. But for many, the cancer eventually finds a way to resist treatment leaving patients facing uncertainty and fewer options. Luke and his team’s PCR-supported project was investigating why this happens so that we can find ways to stop it and keep treatment working for longer. Find out more here.

You can watch the webinar presentation below.

Press enter or esc to cancel